Research-use-only guide. It explains what Semax is and how to compare listings and documentation. It does not give dosing, administration or health advice. Supplier links are affiliate links; see below.
Born in a Moscow lab
Most research peptides reached the market by way of Western pharmaceutical companies, a few academic papers and, eventually, internet forums. Semax has a different lineage. It was designed in the 1980s at the Institute of Molecular Genetics of the Russian Academy of Sciences in Moscow, by a group of chemists and pharmacologists working with the peptide hormone ACTH, and it has been part of the Russian pharmacopoeia ever since. Much of what is known about it appears in Russian-language journals, with a smaller volume of English-language work, and nearly all of that research originates from a handful of linked laboratories.
That background shapes how the compound should be read. In Russia, Semax is registered as a medicine, available as nasal drops for certain neurological uses. Outside Russia, and in particular in the United States and the European Union, it has no marketing authorisation. When a Western vendor describes Semax with the confidence of an established drug, they are borrowing the status of a product that is regulated in one country and unregulated in most others. This site does not sell or advise on using it; this page deals with the research material.
A fragment, with a tail
ACTH, adrenocorticotropic hormone, is a 39-amino-acid peptide released by the pituitary gland to signal the adrenal glands. Different pieces of it do different things. The stretch from residue 4 to residue 10, whose sequence is Met-Glu-His-Phe-Arg-Trp-Gly, was found in the 1960s to influence attention and learning in animals without triggering the hormonal effects of the full molecule. The problem with a seven-residue fragment is durability: enzymes dismantle it within minutes.
The Moscow group's solution was to replace the last three residues, Arg-Trp-Gly, with Pro-Gly-Pro. The result is Met-Glu-His-Phe-Pro-Gly-Pro, seven residues and about 814 daltons. Proline-rich tails resist the exopeptidases that chew peptides from the end, and the change dramatically extends how long the molecule survives in biological fluid. It also removes the tryptophan, which is one of the easily oxidised residues. What remains has no appreciable hormonal activity, which was a design goal.
What the research literature reports
Published work on Semax spans animal studies, cell experiments and a limited number of clinical studies in Russia. In rodents, researchers have reported effects on gene expression in the hippocampus, including increases in the neurotrophin BDNF and its receptor, along with behavioural changes in learning tasks. Russian clinical reports describe its use in stroke rehabilitation and cognitive disorders. Reviews note that many of these studies were small, many were open-label rather than blinded, and independent replication outside the originating network is limited.
That does not make the work worthless, but it is a reason for caution. A drug that is registered in one country on the basis of local studies has not necessarily met the evidence standard that Western regulators demand. We therefore describe the literature and do not draw conclusions about effects.
Three forms you will meet
Semax is not one product on the retail market but at least three, and listings often blur them.
The base peptide is the seven-residue sequence above, sold as a lyophilised powder in a vial. It is what the COA conventions in this guide mainly address.
N-acetyl Semax amidate adds an acetyl group at the front and an amide at the end. Both modifications are meant to protect the molecule further. It is a distinct compound with a different mass, around 855 daltons. Sellers who offer it describe it as a stronger or longer-lasting version, but I have not seen independent comparison data, and the claim should be read as marketing.
Nasal spray products are premixed solutions in a dispenser. These contain solvents, buffers and often preservatives, and are subject to a different set of quality questions, including concentration accuracy, sterility and stability in solution. A COA for the lyophilised peptide does not answer them. One of the suppliers below lists a Semax spray alongside a vial, so be sure which one you are comparing.
Reading the paperwork
| Base peptide mass | About 814 Da (Met-Glu-His-Phe-Pro-Gly-Pro). |
|---|---|
| N-acetyl amidate mass | About 855 Da. A COA showing this mass on a product titled plain Semax is a mislabel. |
| Chromatogram | Full trace. For a short peptide, a single dominant peak should be achievable; extra peaks deserve a question. |
| Methionine | Position 1 is a methionine, which can oxidise (+16 Da, about 830). Check for a satellite peak. |
| Counter-ion | Acetate or TFA, which affects the net peptide content of the powder. |
| Batch details | Lot, test date and laboratory name, matching the vial. |
Because the peptide is short, the difficulty is not synthesis, which any competent laboratory can do. The difficulty is knowing what you were sold. Mix-ups between the base peptide and its acetylated variant are the most likely error, and the mass spectrum resolves them at once. If a COA lacks a spectrum, that resolution is unavailable to you.
Reading the Russian-language literature critically
A curious reader will quickly run into papers that are not in English, and into English summaries that cite them. A few habits help. Look for the sample size and whether the study was randomised and blinded; note whether the authors have a connection to the institute that developed the compound; and check whether the formulation used in the study is the one being discussed. Many Russian clinical reports used a nasal solution made to a specific concentration, which is not the same as a lyophilised vial from a research supplier. Be sceptical, too, of review articles that repeat the same handful of citations. When a claim traces back to a single laboratory, treat it as a hypothesis awaiting independent confirmation. That is not a criticism of the science, much of which is competent, only a recognition of how evidence accumulates. It is the same stance we take when we assess supplier claims: ask what the source is, who benefits from the statement, and whether anyone outside the originating group has checked it.
Semax and its sibling
Semax is often discussed together with Selank, another Pro-Gly-Pro heptapeptide from the same Moscow tradition. The two share a stabilising tail but come from entirely different parents, Semax from ACTH and Selank from the immune peptide tuftsin. They are not interchangeable, and results reported for one say nothing reliable about the other. For a different small peptide of immune-signal origin, see KPV.
Where to find it
Three suppliers in our directory list Semax. I have not ordered from any of them for this page; the notes reflect public listings. Check which form each one sells.
Iron Peptides lists Semax as a vial. Code IRONMAN gives 10% off. See our Iron Peptides review; the company is also a sponsored listing on this site.
Next Gen Peps lists Semax, and publishes a COA library for its catalog. See our Next Gen Peps review.
Vortex Research lists Semax as a vial and also sells a Semax spray under a separate product. The link here goes to the vial. Its PEPPERS code is advertised at 30% off. It has not been reviewed on this site yet.
These are affiliate links. PeptideSuppliers.org may earn a commission if you buy, at no extra cost to you. This does not influence our ratings, and the suppliers are listed alphabetically. See the disclosure.
Common questions
Is Semax an approved drug?
In Russia it is registered as a medicine. In the United States and the European Union it has no approval.
Is it a form of ACTH?
It is built from a fragment of ACTH but has been modified and lacks the hormone's activity on the adrenal glands.
Why does the tail matter?
Pro-Gly-Pro is meant to protect the molecule from enzymes that would otherwise degrade it, which extends its lifetime in biological fluid.
To compare all suppliers, see the supplier database.
For laboratory research use only. Not medical advice; no claims about safety, legality or fitness for any use. See the medical disclaimer.